Publications by authors named "Neil Bander"

Claim this Profile
B
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.
Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos, Alexander Martinez-Fundichely, Michael Sun, Neil H Bander

Prostate· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of Ac-J591.
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, Michael Sun, Judith Stangl-Kremser, Neil H Bander

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer.
Lena M Unterrainer, Jeremie Calais, Neil H Bander

Annu Rev Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
Judith Stangl-Kremser, Michael Sun, Benedict Ho, Joseph Thomas, Jones T Nauseef, Neil H Bander

Prostate· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States.
Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Neil Bander

J Nucl Med Technol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.
Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Kritika Subramanian, Joseph R Osborne, Michael Sun, Neil H Bander

Prostate· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
Erolcan Sayar, Radhika A Patel, Ilsa M Coleman, Martine P Roudier, Ailin Zhang, Neil H Bander

JCI Insight· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: [Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Simone Krebs, Christian Grommes, Michael R McDevitt, Sean D Carlin, Joseph A O'Donoghue, Neil H Bander

Eur J Nucl Med Mol Imaging· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of the diagnostic utility of Zr-df-IAB2M and Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer.
Panagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, Paul J Christos, Joseph R Osborne, Neil H Bander

Prostate· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Simone Krebs, Christian Grommes, Michael R McDevitt, Sean D Carlin, Joseph A O'Donoghue, Neil H Bander

Eur J Nucl Med Mol Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to Prostatectomy.
Joseph R Osborne, Neil H Bander, Scott T Tagawa

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
Teja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, Goutam Chakraborty, Myrto Skafida, Neil H Bander

Eur J Nucl Med Mol Imaging· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer.
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida, Seyed Ali Mosallaie, Charlene Thomas, Neil Harrison Bander

Prostate· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Prostate-specific Membrane Antigen-based Therapeutics: Small Molecules, Antibodies, and Beyond.
Jones T Nauseef, Neil H Bander, Scott T Tagawa

Eur Urol Focus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer.
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, Seyed Ali Mosallaie, Charlene Thomas, Neil H Bander

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.
Jaspreet S Batra, Muhammad Junaid Niaz, Young E Whang, Arif Sheikh, Charlene Thomas, Neil H Bander

Urol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.
Andrea K Miyahira, Kenneth J Pienta, John W Babich, Neil H Bander, Jeremie Calais

Prostate· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 ( Lu-J591) for Metastatic Castration-Resistant Prostate Cancer.
Muhammad Junaid Niaz, Jaspreet S Batra, Ryan D Walsh, Marigdalia K Ramirez-Fort, Shankar Vallabhajosula, Neil H Bander

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management).
Marc J Rogers, Marigdalia K Ramirez-Fort, James A Kashanian, Seth A Broster, Jaime Matta, Neil H Bander

Rep Pract Oncol Radiother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.
Scott T Tagawa, Shankar Vallabhajosula, Paul J Christos, Yuliya S Jhanwar, Jaspreet S Batra, Neil H Bander

Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer.
Song Cho, Francesca Zammarchi, David G Williams, Carin E G Havenith, Noel R Monks, Neil H Bander

Mol Cancer Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation.
Wilhem Leconet, He Liu, Ming Guo, Sophie Le Lamer-Déchamps, Charlotte Molinier, Neil H Bander

Mol Cancer Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.
Andrea K Miyahira, Kenneth J Pienta, Michael J Morris, Neil H Bander, Richard P Baum

Prostate· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
Douglas G McNeel, Neil H Bander, Tomasz M Beer, Charles G Drake, Lawrence Fong

J Immunother Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis